- Homepage of Essential Inventions,
the non-profit corporation which petitioned the US Department of Health and
Human Services for licenses to manufacture and sell inexpensive generic
versions of Xalatan and Norvir.
The Bayh-Dole Act allows for the transfer of exclusive control
over many government funded inventions to universities and
businesses operating with federal contracts for the purpose of
further development and commercialization. The contracting
universities and businesses are then permitted to exclusively
license the inventions to other parties. The federal government,
however, retains "March-in" rights to license the invention to a
third party, without the consent of the patent holder or original
licensee, where it determines the invention is not being made a
vailable to the public on a reasonable basis, (in other words,
to issue a
Efforts to Have the NIH License the World Health Organization the Rights to
Its Health Patents
- March 28, 2001.
Letter from Ralph Nader, James Love, and Robert Weissman to US Secretary of
Health and Human Services Tommy Thompson.
- October 19, 1999.
Letter from NIH Director, Dr. Harold Varmus to Ralph
Nader, James Love and Robert Weissman responding to their request
calling on the NIH to provide the World Health Organization, WHO, access
to US government funded medical inventions.
- September 3, 1999.
Letter from Ralph Nader, James Love, and Robert Weissman to NIH Director
Harold Varmus asking for NIH to give the World Health Organization,
WHO, access to US government funded medical inventions.
- September 78, 2005. Clifton Leaf in Fortune Magazine.
The Law of Unintended Consequences.
- December 16, 2004. Jane Burgermeister for the Nature Publishing Group.
Hungarian Parliament expected to pass a new innovation law.
- April 2004. Shannon Brownlee for the Washington Monthly.
Doctors Without Borders - Why You Can't Trust Medical Journals Anymore.
- January 12, 2003. Jane Larson for the Arizona Republic.
Tech transfer on table: Inventors, governor eager to change law.
- December 14, 2002. The Economist.
Innovation's Golden Goose.
- March 27, 2002. Op-ed by Peter Arno and Michael Davis in the
Paying Twice for the Same Drugs.
- January 21, 2002. Joseph Paone for The Scientist.
When Big Pharma Courts Academia.
- June 13, 2000. Judith Gorman for AlteNnet.
PAPER CUTS: The Golden Fleece.
- 1998, Winter. Michael Odoza for 21st Centery MetaNews, vol. 3-1.
From the Ivory Tower to the Marketplace. This story is from
an issue of the publication devoted exclusively to technology transfer
from university to pivate enterprise. Here is the
URL for the full issue.